US EditionPoint72 Asia Singapore Pte. Ltd. Acquires New Position in Blueprint Medicines Co. (NASDAQ:BPMC)
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Point72 Asia Singapore Pte. Ltd. Acquires New Position in Blueprint Medicines Co. (NASDAQ:BPMC)
Point72 Asia Singapore Pte. Ltd. bought a new stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,220 shares of the biotechnology company’s stock, valued at approximately $106,000. Several other institutional investors also recently made […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
